| RS2516164780 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516164897 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516165624 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516165933 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516166292 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516167210 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516167273 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516167608 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516167961 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516168233 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516169508 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516169701 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516170525 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516170535 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516171041 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Thyroid cancer, nonmedullary |
| RS2516172821 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516172888 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516173100 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516173144 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516174223 |
POFUT1
|
Health Risk |
Pathogenic |
Dowling-Degos disease 2, Dowling-Degos disease 2 |
| RS2516175715 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516175807 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516175842 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516175890 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516175979 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516176081 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516177016 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2516177430 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516177505 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516177530 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2516180932 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516181122 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516185027 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2516185103 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516185345 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516186456 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516186640 |
NDUFAF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516186898 |
NDUFAF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516187432 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS2516187638 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516187639 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2516188649 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516188730 |
NDUFAF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516188853 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS2516189091 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2516189150 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516189237 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516193520 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2516196116 |
PRPF31
|
Health Risk |
Likely pathogenic |
— |
| RS2516196919 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516197070 |
ADA
|
Health Risk |
Likely pathogenic |
— |
| RS2516197108 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS2516197396 |
PRPF31
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2516204990 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2516205141 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2516205158 |
PRPF31
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2516205278 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2516206256 |
PRPF31
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2516206308 |
PRPF31
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2516206372 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2516206637 |
PRPF31
|
Health Risk |
Pathogenic |
PRPF31-related disorder, PRPF31-related disorder |
| RS2516208014 |
PRPF31
|
Health Risk |
Pathogenic |
— |
| RS2516230862 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2516231282 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2516232840 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS2516234229 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS2516235312 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS2516237462 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516244932 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS2516260557 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS2516270105 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516270378 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516270409 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2516270551 |
NDUFAF5
|
Health Risk |
Pathogenic |
— |
| RS2516273685 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516274126 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516274344 |
NDUFAF5
|
Health Risk |
Likely pathogenic |
Mitochondrial complex I deficiency, nuclear type 16 |
| RS2516279954 |
CEP250
|
Health Risk |
Pathogenic |
— |
| RS2516310445 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Autosomal dominant epilepsy, Autosomal dominant epilepsy |
| RS2516345389 |
CYP24A1
|
Health Risk |
Likely pathogenic |
CYP24A1-related disorder, CYP24A1-related disorder |
| RS2516352608 |
CYP24A1
|
Health Risk |
Likely pathogenic |
— |
| RS2516362777 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516364122 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516364365 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516364432 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516364470 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516364667 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516364978 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizures, benign familial neonatal |
| RS2516365119 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2516370196 |
GNAS
|
Health Risk |
Likely pathogenic |
Pseudohypoparathyroidism type 1B, Pseudohypoparathyroidism type 1B |
| RS2516371188 |
GNAS
|
Health Risk |
Likely pathogenic |
— |
| RS2516376283 |
CYP24A1
|
Health Risk |
Pathogenic |
Hypercalcemia, infantile |
| RS2516381362 |
ATP9A
|
Health Risk |
Likely pathogenic |
— |
| RS2516384106 |
ATP9A
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with poor growth and behavioral abnormalities, Neurodevelopmental disorder with poor growth and behavioral abnormalities |
| RS2516400177 |
CYP24A1
|
Health Risk |
Pathogenic |
— |
| RS2516403268 |
CYP24A1
|
Health Risk |
Likely pathogenic |
Hypercalcemia, infantile |
| RS2516403351 |
CYP24A1
|
Health Risk |
Pathogenic |
— |
| RS2516404261 |
CYP24A1
|
Health Risk |
Pathogenic |
Hypercalcemia, infantile |
| RS2516405173 |
CYP24A1
|
Health Risk |
Likely pathogenic |
Hypercalcemia, infantile |
| RS2516408449 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizure, Early-infantile DEE |